M. Monici, F. Cialdai, F. Fusi, G. Romano, R. Pratesi
Energy for Health [03], 26-33, 2009
Lasers have been widely applied in many different fields of medicine, proving their effectiveness in the treatment of a wide range of diseases. In spite of the great amount of literature, it is difficult to understand the molecular and cellular mechanisms at the basis of the systemic effects induced by laser irradiation because of different kinds of laser used, operative conditions, variety of biological targets and responses. The application of high power lasers in physiotherapy is quite recent. It is due to the development of instruments which allow the control of photothermal and photomechanical processes so as to obtain therapeutic effects without tissue damage. In particular, pulsed Nd:YAG laser has proved hisversatility and efficacy in the treatment of many different musculoskeletal diseases and it is believed to have antinflammatory, antipedema, analgesic and also reparative effects. The aim ofthe studies here presented was to contribute in understanding the molecular mechanisms and cellular processes at the basis of the systemic effects produced by pulsed Nd:YAG laser irradiation. Owing to the lack of chromophores efficiently absorbing Nd:YAG radiation (wavelength 1064 nm) in cells and tissues, we hypothesized that, rather than photochemical processes, aspecific mechanisms probably due to combined photothermal and photomechanical interactions could be responsible for the above mentioned effects of pulsed Nd:YAG laser. The finding suggestthat cells “sense" pulsed ND:YAG laser irradiation and respond to it through mechanotransduction machinery. We hypothesize that the interaction between tissue and laser radiation alters the mechanics of cell microenvironment, thus acting on the cells as a mechanical stress.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.